Isofol Medical AB (publ)

Isofol Medical AB (publ) - Enterprise Valueverified

ISOFOL.ST

Price:

$0.83

Market Cap:

$266.01M

Isofol Medical AB (publ) is a clinical-stage biotechnology firm dedicated to the research, marketing, and global distribution of oncology medications, with operations both in Sweden and abroad. Its leading therapeutic candidate, arfolitixorin, is presently undergoing Phase 3 clinical trials for individuals with advanced colorectal cancer. The company has forged significant strategic alliances with organizations including Recipharm, Merck & Cie, and Sahlgrenska University Hospital. Established in 2008, its corporate base is situated in Gothenburg, Sweden.

Industry

Biotechnology

IPO Date

2017-04-04

Stock Exchange

STO

Ticker

ISOFOL.ST

The Enterprise Value as of July 2026 (TTM) for Isofol Medical AB (publ) (ISOFOL.ST) is 210.27M

According to Isofol Medical AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 210.27M. This represents a change of 65.24% compared to the average of 127.25M of the last 4 quarters.

Isofol Medical AB (publ) (ISOFOL.ST) Historical Enterprise Value (quarterly & annually)

How has ISOFOL.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Isofol Medical AB (publ) over the last ten years is 622.19M. The current 210.27M Enterprise Value has changed 3.28% with respect to the historical average. Over the past ten years (40 quarters), ISOFOL.ST's Enterprise Value was at its highest in in the December 2020 quarter at 2.22B. The Enterprise Value was at its lowest in in the June 2023 quarter at -74555641.04.

Quarterly (TTM)
Annual

Average

622.19M

Median

733.40M

Minimum

-67113574.40

Maximum

1.61B

Isofol Medical AB (publ) (ISOFOL.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Isofol Medical AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 58.04%

Maximum Annual Enterprise Value = 1.61B

Minimum Annual Increase = -1375.93%

Minimum Annual Enterprise Value = -67113574.40

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025115.96M-55.64%
2024261.41M-1375.93%
2023-20487869.47-69.47%
2022-67113574.40-108.57%
2021783.17M-51.29%
20201.61B58.04%
20191.02B-3.75%
20181.06B46.63%
2017720.81M-3.38%
2016746.00M-5.19%

Isofol Medical AB (publ) (ISOFOL.ST) Average Enterprise Value

How has ISOFOL.ST Enterprise Value performed in the past?

The current Enterprise Value of Isofol Medical AB (publ) (ISOFOL.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

118.96M

5-year avg

214.59M

10-year avg

622.19M

Isofol Medical AB (publ) (ISOFOL.ST) Enterprise Value vs. Peers

How is ISOFOL.ST’s Enterprise Value compared to its peers?

Isofol Medical AB (publ)’s Enterprise Value is greater than Annexin Pharmaceuticals AB (75.37M), greater than IRLAB Therapeutics AB (publ) (97.53M), less than Lipum AB (publ) (302.84M), greater than Initiator Pharma A/S (110.49M), greater than Karolinska Development AB (publ) (-36341758.00), greater than Enorama Pharma AB (publ) (1.26M), less than Bio-Works Technologies AB (publ) (244.35M), greater than Clinical Laserthermia Systems AB (publ) (74.66M), greater than Alzinova AB (publ) (61.55M), greater than Xbrane Biopharma AB (publ) (121.62M),

Build a custom stock screener for Isofol Medical AB (publ) (ISOFOL.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Isofol Medical AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Isofol Medical AB (publ) (ISOFOL.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Isofol Medical AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Isofol Medical AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Isofol Medical AB (publ) (ISOFOL.ST)?

What is the 3-year average Enterprise Value for Isofol Medical AB (publ) (ISOFOL.ST)?

What is the 5-year average Enterprise Value for Isofol Medical AB (publ) (ISOFOL.ST)?

How does the current Enterprise Value for Isofol Medical AB (publ) (ISOFOL.ST) compare to its historical average?